Editor
Clover Health’s outlook continues to darken as the company settles the first of several shareholder class-action lawsuits and struggles to remain listed on the Nasdaq Stock Exchange.
The health insurance startup agreed to pay $22 million to resolve shareholder allegations that it committed securities fraud by failing to disclose a Justice Department investigation and other important information about its operations prior to its initial…
